中外医疗
中外醫療
중외의료
CHINA FOREIGN MEDICAL TREATMENT
2015年
23期
167-168,183
,共3页
肺癌%CT%PET-CT%血清肿瘤标记物
肺癌%CT%PET-CT%血清腫瘤標記物
폐암%CT%PET-CT%혈청종류표기물
Lung cancer%CT%PET-CT%Tumor marker
目的：CT与18F-FDG正电子发射型计算机断层显像( positron emission tomography,18F-FDG PET-CT)联合血清肿瘤标记物对于不同临床分期肺癌诊断准确率的比较。方法整群选取2013年8月—2014年12月该院收治的81例经手术或穿刺活检、细胞灌洗细胞学检查、临床随访、诊断性治疗等方法诊断为肺癌的患者,其中74例有明确病理组织学类型。全部患者均在术前行肺部CT、血清肿瘤标记物检测及肺部PET-CT扫描。分析它们对不同临床分期肺癌诊断准确率的有无差异。结果CT与肿瘤标记物联合检测对肺癌的准确率为84.21%,PET-CT与肿瘤标记物联合检测的准确率为92.10%,差异有统计学意义(P<0.05)。74例有明确病理组织学类型的患者,其中鳞癌38例,诊断准确率分别为84.2%、94.7%,差异有统计学意义(P<0.05)；腺癌28例,诊断准确率分别为85.7%、96.4%；小细胞型肺癌6例,诊断准确率分别66.67%、83.33%；大细胞肺癌和鳞腺癌各1例,诊断准确率均为100%、100%。结论18F-FDG PET-CT联合血清肿瘤标记物对肺癌的诊断率高于CT联合肿瘤标记物检查,对肺癌的诊断有很高价值。
目的：CT與18F-FDG正電子髮射型計算機斷層顯像( positron emission tomography,18F-FDG PET-CT)聯閤血清腫瘤標記物對于不同臨床分期肺癌診斷準確率的比較。方法整群選取2013年8月—2014年12月該院收治的81例經手術或穿刺活檢、細胞灌洗細胞學檢查、臨床隨訪、診斷性治療等方法診斷為肺癌的患者,其中74例有明確病理組織學類型。全部患者均在術前行肺部CT、血清腫瘤標記物檢測及肺部PET-CT掃描。分析它們對不同臨床分期肺癌診斷準確率的有無差異。結果CT與腫瘤標記物聯閤檢測對肺癌的準確率為84.21%,PET-CT與腫瘤標記物聯閤檢測的準確率為92.10%,差異有統計學意義(P<0.05)。74例有明確病理組織學類型的患者,其中鱗癌38例,診斷準確率分彆為84.2%、94.7%,差異有統計學意義(P<0.05)；腺癌28例,診斷準確率分彆為85.7%、96.4%；小細胞型肺癌6例,診斷準確率分彆66.67%、83.33%；大細胞肺癌和鱗腺癌各1例,診斷準確率均為100%、100%。結論18F-FDG PET-CT聯閤血清腫瘤標記物對肺癌的診斷率高于CT聯閤腫瘤標記物檢查,對肺癌的診斷有很高價值。
목적：CT여18F-FDG정전자발사형계산궤단층현상( positron emission tomography,18F-FDG PET-CT)연합혈청종류표기물대우불동림상분기폐암진단준학솔적비교。방법정군선취2013년8월—2014년12월해원수치적81례경수술혹천자활검、세포관세세포학검사、림상수방、진단성치료등방법진단위폐암적환자,기중74례유명학병리조직학류형。전부환자균재술전행폐부CT、혈청종류표기물검측급폐부PET-CT소묘。분석타문대불동림상분기폐암진단준학솔적유무차이。결과CT여종류표기물연합검측대폐암적준학솔위84.21%,PET-CT여종류표기물연합검측적준학솔위92.10%,차이유통계학의의(P<0.05)。74례유명학병리조직학류형적환자,기중린암38례,진단준학솔분별위84.2%、94.7%,차이유통계학의의(P<0.05)；선암28례,진단준학솔분별위85.7%、96.4%；소세포형폐암6례,진단준학솔분별66.67%、83.33%；대세포폐암화린선암각1례,진단준학솔균위100%、100%。결론18F-FDG PET-CT연합혈청종류표기물대폐암적진단솔고우CT연합종류표기물검사,대폐암적진단유흔고개치。
Objective CT and 18F-FDG combined with serum tumor markers positron emission tomography (18F-FDG PET-CT) for the comparison of the diagnostic accuracy of different clinical stages of lung cancer. Methods Collected 81 cases by surgery or biopsy, cells lavage cytology, clinical follow-up, diagnostic treatment method for the diagnosis of lung cancer patients, including 74 cases of clear histological types. All patients in the preoperative lung CT, PET-CT, serum tumor markers detection and lung scan. Analysis of their differences on the presence or absence of the different clinical stages of lung cancer diagnostic accuracy. Results CT and tumor markers combined detection of lung cancer, the accuracy rate is 84.21%, PET-CT and tumor markers combined de-tection rate of 92.10%difference was statistically significant (P<0.05). 74 cases of the clear histological types of patients, including squamous cell carcinoma in 38 cases, the diagnostic accuracy rate of 84.2%, 94.7%, and the difference was statistically significant (P<0.05);Adenocarcinoma in 28 cases, the diagnostic accuracy rate were 85.71%, 92.86%;Six cases of small cell lung cancer, di-agnostic accuracy rates were 66.7%, 83.3%; Large cell lung cancer and squamous carcinoma in 1 case, the diagnostic accuracy rate of 100%, 100%. Conclusion 18F-FDG PET-CT combined with tumor markers diagnosis of lung cancer is higher than CT combined with tumor markers check, has a high value in the diagnosis of lung cancer.
